Lexpos News

/Lexpos News

CPCF services and Terms of Service – Important dates page

We have published a new page on our website which provides a list of important dates for the Community Pharmacy Contractual Framework (CPCF) which relate to national pharmacy services (Advanced services and National Enhanced services). The page also highlights important dates for Terms of Service (ToS) requirements, as well as dates when relevant news stories [...]

The post CPCF services and Terms of Service – Important dates page appeared first on Community Pharmacy England.

By |December 13th, 2023|Lexpos News|Comments Off on CPCF services and Terms of Service – Important dates page

Reminder: Check your referred back/disallowed prescriptions on MYS before they expire in January 2024

The October 2023 Drug Tariff was updated to include a deadline for submission of any outstanding referred back (unpaid) prescriptions to the NHS Business Services Authority (NHSBSA) for payment. Following this update, NHSBSA has seen a spike in the number of  referred back prescriptions submitted by pharmacies in the past month. The January 2024 Drug [...]

The post Reminder: Check your referred back/disallowed prescriptions on MYS before they expire in January 2024 appeared first on Community Pharmacy England.

By |December 13th, 2023|Lexpos News|Comments Off on Reminder: Check your referred back/disallowed prescriptions on MYS before they expire in January 2024

Class 4 Medicines Defect Information: Clobazam 5mg/5ml and 10mg/5ml oral suspension (Atnahs Pharma UK Limited)

Class 4 Medicines Defect Information: Clobazam 5mg/5ml and 10mg/5ml oral suspension (Atnahs Pharma UK Limited) Drug alert number: EL(23)A/43 Date issued: 13 December 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Clobazam 5mg/5ml and 10mg/5ml oral suspension (Atnahs Pharma UK Limited) Company name: Atnahs [...]

The post Class 4 Medicines Defect Information: Clobazam 5mg/5ml and 10mg/5ml oral suspension (Atnahs Pharma UK Limited) appeared first on Community Pharmacy England.

By |December 13th, 2023|Lexpos News|Comments Off on Class 4 Medicines Defect Information: Clobazam 5mg/5ml and 10mg/5ml oral suspension (Atnahs Pharma UK Limited)

Update – LFD service: Provider Assurance activity begins

Update – 19th December 2023 – There has been an update to the process, below, that the PAT will follow. The NHS Business Services Authority (NHSBSA) Provider Assurance Team (PA Team) will soon start to undertake provider assurance work with pharmacy owners providing the Lateral Flow Devices (LFD) test supply service. The reviews, commissioned by [...]

The post Update – LFD service: Provider Assurance activity begins appeared first on Community Pharmacy England.

By |December 13th, 2023|Lexpos News|Comments Off on Update – LFD service: Provider Assurance activity begins

NHS England publishes vaccination strategy

NHS England has published its vaccination strategy, on which it consulted with stakeholders and the public in the autumn of last year. Read the vaccination strategy A key proposal within the strategy is to delegate commissioning responsibility for vaccination services, which currently rests with NHS England, to integrated care boards (ICB). This follows similar delegation [...]

The post NHS England publishes vaccination strategy appeared first on Community Pharmacy England.

By |December 13th, 2023|Lexpos News|Comments Off on NHS England publishes vaccination strategy